Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: Added value of unenhanced CT compared with conventional contrast-enhanced MR imaging

Radiology

Volumn 251, Issue 2, 2009, Pages 467-475

  Dae, Sik Kim ^a   Dong, Gyu Na ^a,c   Keon, Ha Kim ^b   Kim, Ji Hoon ^a   Kim, Eunhee ^a   Bo, La Yun ^a   Chang, Kee Hyun ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; CONTRAST MEDIUM;

ADULT; ARTICLE; BRAIN LYMPHOMA; BRAIN REGION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; FEMALE; GLIOMA; HUMAN; INTERMETHOD COMPARISON; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TUMEFACTIVE DEMYELINATING LESION; BRAIN TUMOR; COMPARATIVE STUDY; IMAGE ENHANCEMENT; LYMPHOMA; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; BRAIN NEOPLASMS; CONTRAST MEDIA; DEMYELINATING DISEASES; FEMALE; GLIOMA; HUMANS; IMAGE ENHANCEMENT; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 66149124485     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2512072071     Document Type: Article

References (25)

1. Dagher AP, Smirniotopoulos J. Tumefactive demyelinating lesions. Neuroradiology 1996;38:560-565. (Pubitemid 26288246)
2. Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? a study of 31 patients. Ann Neurol 1993;33:18-27. (Pubitemid 23009905)
3. Masdeu JC, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P. Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 2000;54:1427-1433. (Pubitemid 30210460)
4. Masdeu JC, Moreira J, Trasi S, Visintainer P, Cavaliere R, Grundman M. The open ring: a new imaging sign in demyelinating disease. J Neuroimaging 1996;6:104-107. (Pubitemid 26127343)
5. Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2001;22:1109-1116.
6. Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991;180:467-474.
7. Selkirk SM, Shi J. Relapsing-remitting tumefactive multiple sclerosis. Mult Scler 2005;11:731-734. (Pubitemid 41685148)
8. Khoshyomn S, Braff SP, Penar PL. Tumefactive multiple sclerosis plaque. J Neurol Neurosurg Psychiatry 2002;73:85. (Pubitemid 34713024)
9. Schwartz KM, Erickson BJ, Lucchinetti C. Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology 2006;48:143-149. (Pubitemid 43380226)
10. Chakrabortty S, Nagashima T, Saitoh M, Hanada Y, Hiyama K, Tamaki N. Intracerebral ring-enhancing lesions in a patient with multiple sclerosis: a case report. Surg Neurol 1995;43:591-594.
11. Otsuka S, Nakatsu S, Matsumoto S, et al. Multiple sclerosis simulating brain tumor on computed tomography. J Comput Assist Tomogr 1989;13:674-678.
12. Tan HM, Chan LL, Chuah KL, Goh NS, Tang KK. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis. Br J Radiol 2004;77:153-156. (Pubitemid 38313232)
13. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34:661-669. (Pubitemid 23333237)
14. Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-793. (Pubitemid 27481551)
15. Loevner LA, Grossman RI, McGowan JC, Ramer KN, Cohen JA. Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. AJNR Am J Neuroradiol 1995;16:1473-1479.
16. van Waesberghe JH, van Walderveen MA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998;19:675-683.
17. Nusbaum AO, Lu D, Tang CY, Atlas SW. Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images. AJR Am J Roentgenol 2000;175:821-825.
18. Ernst T, Chang L, Walot I, Huff K. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology 1998;51:1486-1488. (Pubitemid 28520589)
19. Enzinger C, Strasser-Fuchs S, Ropele S, Kapeller P, Kleinert R, Fazekas F. Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging. Mult Scler 2005;11:135-139. (Pubitemid 40403249)
20. Sagiuchi T, Oka H, Utsuki S, et al. Increased accumulations of N-isopropyl-p-[123I]-iodoamphetamine related to tumefactive multiple sclerosis. Ann Nucl Med 2005;19:603-606.
21. Rovira A, Pericot I, Alonso J, Rio J, Grivé E, Montalban X. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol 2002;23:989-994. (Pubitemid 34663446)
22. Bernarding J, Braun J, Koennecke HC. Diffusion and perfusion-weighted MR imaging in a patient with acute demyelinating encephalomyelitis (ADEM). J Magn Reson Imaging 2002;15:96-100. (Pubitemid 34008152)
23. Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619-1627.
24. Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002;23:1378-1386.
25. Omuro AM, Leite CC, Mokhtari K, Delattre JY. Pitfalls in the diagnosis of brain tumours. Lancet Neurol 2006;5:937-948. (Pubitemid 44574407)